Full Text View
Tabular View
No Study Results Posted
Related Studies
Use of Levemir® Improves Metabolic and Clinical Status in Cystic Fibrosis-related Diabetes (CFRD)
The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2009 by Nationwide Children's Hospital.
Recruitment status was  Recruiting
Study NCT00639626   Information provided by Nationwide Children's Hospital

First Received on March 14, 2008.   Last Updated on August 10, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cystic Fibrosis Related Diabetes
Additional conditions recognized in this trial
Cystic Fibrosis
Diabetes Mellitus
Fibrosis
More general conditions related to this trial
Digestive System Diseases
Endocrine System Diseases
Genetic Diseases, Inborn
Glucose Metabolism Disorders
Infant, Newborn, Diseases
Lung Diseases
Metabolic Diseases
Pancreatic Diseases
Pathologic Processes
Respiratory Tract Diseases
Sponsors listed in this trial
Nationwide Children's Hospital
Novo Nordisk


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services